Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
---|
Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
---|
Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
---|
TELA Bio (NASDAQ:TELA) reported its Q3 earnings results on Thursday, November 9, 2023 at 04:03 PM.
Here's what investors need to know about the announcement.
TELA Bio beat estimated earnings by 8.16%, reporting an EPS of $-0.45 versus an estimate of $-0.49.
Revenue was up $3.89 million from the same period last year.
Last quarter the company beat on EPS by $0.07 which was followed by a 3.31% drop in the share price the next day.
Here's a look at TELA Bio's past performance:
Quarter | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
---|---|---|---|---|
EPS Estimate | -0.53 | -0.56 | -0.55 | -0.63 |
EPS Actual | -0.46 | -0.63 | -0.52 | -0.64 |
Revenue Estimate | 14.40M | 12.02M | 13.19M | 10.86M |
Revenue Actual | 14.49M | 11.91M | 11.62M | 11.16M |
To track all earnings releases for TELA Bio visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: TELA